Skip to navigation Skip to content

Partnerships

We’re a health partner of choice for pharmaceutical licensing and acquisitions, with a proven track record of growth through partnerships.

  •  
    distribution 
    partners
  •  
    products in 
    the pipeline
  •  
    team members 
    worldwide
  •  

    countries 
    served

  •  

    years and 
    counting

Unlocking new possibilities together

Together with our trusted partners, we’re meeting patients’ needs throughout their lives with a fast-expanding portfolio of generic medicines, a growing number of innovative branded pharmaceuticals and biosimilars, and high-quality over the counter and natural health products.
Pharmacist working with a patient

Creating access to best-in-class generics

We’re tackling some of the most pressing health challenges of today and tomorrow through partnerships, providing access to best-in-class generic medicines to millions around the world.
Woman working in laboratory
United States

 

Committed to delivering high quality generics, we have a strong market position in the U.S. with a highly scalable foundation and a significant product portfolio of more than 129 products across 12 therapeutic areas.  

 


Canada

We’re the market leader in generics in Canada with over 400 products across 16 therapeutic areas, such as oncology, ophthalmology, women's health, allergy/central nervous system, dermatology and consumer health. 


Latin America

We operate in 9 countries across Latin America, offering a robust portfolio of generics. 


A robust portfolio of innovative branded medicines and biosimilars

Through strategic partnerships, we’re continually building our specialty and innovative branded pharmaceutical portfolio. With more than 65 products in a variety of therapeutic areas, we’re providing breakthrough treatments where they are needed most.

Oncology

We’re transforming access to therapies in oncology through innovation, development, and partnerships.

  • Apobiologix®
  • Grastofil
  • Lapelga
  • Bambevi
  • Toripalimab

Ophthalmology

Working closely with partners, we have a proven track record of success serving Canadian eyecare professionals and their patients. 

  • IHEEZO
  • Pr Blexten®
  • vevye
  • aflibercept biosimilar
  • Clobetasol Propionate

Women's health

With a steadfast commitment to women’s health, we’re focused on improving lives by bringing the right products to market.

  • Divigel® Estradiol gel
  • Mona Lisa®
  • Nextstellis®
  • Norlutate®
  • Thyroid®

Allergy / Central Nervous System

We’re actively expanding our portfolio of pain management and allergy products through Searchlight Pharma, the specialty pharma division of Apotex.

  • Pr Blexten®
  • Cambia
  • Mona Lisa®

Dermatology

We’re bringing innovative dermatology drugs to Canadian patients including TWYNEO and EPSOLAY. Both products have had encouraging uptake by physicians in the US and we look forward to commercializing them for patients in Canada.

  • Pr Twyneo™
  • Pr Epsolay®

A health partner of choice

Providing our partners with a proven foundation for growth, our global team is dedicated to improving everyday access to affordable, innovative medicines and health products. Our key differentiators include: 

  • Robust portfolio and formulation innovation
  • Specialty sales force across key therapeutic areas
  • Scalable and world-class supply and manufacturing
  • Industry-leading regulatory and legal strategies
  • On time, high-value submissions and approvals for launch excellence
  • Market leadership in commercial excellence and customer focus
  • Qualified, engaged and specialized workforce
"We are truly grateful to Apotex for reposing faith in our capabilities over the years. This journey has been defined by trust, shared vision, and consistent progress." 
Dr. M.S. Mohan, Orbicular Pharmaceutical Technologies
"Formosa Pharma is honored to partner with Apotex, with its storied history and reputation for success." 
Erick Co, President & CEO, Formosa
"We are pleased to enter the Canadian market through this partnership with Apotex, which has a proven track record of success serving Canadian eyecare professionals and their patients." 
Mark L. Baum, Chairman and Chief Executive Officer, Harrow

Partner with us

Through strategic partnerships, we’re providing breakthrough treatments where they are needed most. Discover how we can drive better health outcomes and business growth, together.
Get more information on becoming a partner